Moderna :
MRNA
MRNA
Stock Data
$26.86
$1.37 (5.37%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Moderna Inc is a pioneering biotechnology firm based in Cambridge, Massachusetts, known for its innovative use of messenger RNA (mRNA) to develop vaccines and therapeutics. The company has made significant strides in addressing infectious diseases, including COVID-19, influenza, and more, as well as tackling challenges in immuno-oncology, rare diseases, autoimmune disorders, and cardiovascular diseases. Moderna's portfolio includes both respiratory and latent vaccines, public health vaccines, and treatments for infectious diseases. Additionally, it focuses on systemic secreted, cell surface therapeutics, cancer vaccines, and inhaled pulmonary therapeutics, supported by strategic alliances with global pharmaceutical leaders and research organizations.
All Moderna Articles
114 Articles